96 related articles for article (PubMed ID: 16575466)
21. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level.
Fujimoto M; Oka T; Murata T; Hori M; Ozaki H
Eur J Pharmacol; 2009 Jan; 602(2-3):432-8. PubMed ID: 19059394
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma.
Huang ST; Yang RC; Lee PN; Yang SH; Liao SK; Chen TY; Pang JH
Int Immunopharmacol; 2006 Jun; 6(6):870-9. PubMed ID: 16644472
[TBL] [Abstract][Full Text] [Related]
23. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
24. The effects of different types of statins on proliferation and migration of HGF-induced Human Umbilical Vein Endothelial Cells (HUVECs).
Burgazli KM; Bui KL; Mericliler M; Albayrak AT; Parahuleva M; Erdogan A
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2874-83. PubMed ID: 24254555
[TBL] [Abstract][Full Text] [Related]
25. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.
Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J
Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth.
Berto E; Bozac A; Volpi I; Lanzoni I; Vasquez F; Melara N; Manservigi R; Marconi P
Cancer Gene Ther; 2007 Sep; 14(9):791-801. PubMed ID: 17557110
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
28. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin and fluvastatin extended release: a clinical and safety profile.
Asberg A; Holdaas H
Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):641-52. PubMed ID: 15350166
[TBL] [Abstract][Full Text] [Related]
31. Statins and angiogenesis: is it about connections?
Khaidakov M; Wang W; Khan JA; Kang BY; Hermonat PL; Mehta JL
Biochem Biophys Res Commun; 2009 Sep; 387(3):543-7. PubMed ID: 19615978
[TBL] [Abstract][Full Text] [Related]
32. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
33. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M
Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623
[TBL] [Abstract][Full Text] [Related]
34. Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.
Fukuda D; Enomoto S; Shirakawa I; Nagai R; Sata M
Eur J Pharmacol; 2009 Jun; 612(1-3):87-92. PubMed ID: 19371739
[TBL] [Abstract][Full Text] [Related]
35. Fluvastatin increases heterotopically induced ossicles in mice.
Galus R; Wlodarski PK; Wlodarski KH
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):388-90. PubMed ID: 16620306
[TBL] [Abstract][Full Text] [Related]
36. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipients.
Barlage S; Hauser IA; Elbracht R; Abletshauser C; Schmieder RE; Weidinger G; Lackner KJ; Rothe G; Schmitz G
J Biol Regul Homeost Agents; 2005; 19(3-4):159-68. PubMed ID: 16602632
[TBL] [Abstract][Full Text] [Related]
38. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
[TBL] [Abstract][Full Text] [Related]
39. Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells.
Hashimoto K; Morishige K; Sawada K; Tahara M; Shimizu S; Ogata S; Sakata M; Tasaka K; Kimura T
Biochem Biophys Res Commun; 2007 Mar; 354(2):478-84. PubMed ID: 17240356
[TBL] [Abstract][Full Text] [Related]
40. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
